Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of Older Adult Allogeneic Hematopoietic Cell Transplant Candidates to Improve Survival (OTIS)

NCT05972577 is registered in ClinicalTrials.gov with Ohio State University Comprehensive Cancer Center as lead sponsor.

NCT NCT05972577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05972577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of Older Adult Allogeneic Hematopoietic Cell Transplant Candidates to Improve Survival (OTIS)
Lead sponsor
Ohio State University Comprehensive Cancer Center
Phase
Not applicable
Overall status
Completed
Start date
June 11, 2021
Completion date
November 13, 2024
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, acute myeloid leukemia, aplastic anemia, chronic lymphocytic leukemia, chronic myelogenous leukemia, bcr-abl1 positive, hematopoietic and lymphoid cell neoplasm, hodgkin lymphoma, myelodysplastic syndrome, myelofibrosis, myeloproliferative neoplasm, non-hodgkin lymphoma, plasma cell myeloma